ANC
ABBV icon

Ames National Corp’s AbbVie ABBV Stock Holding History

Ames National Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Hold
1,465
– – 0.2% 53
2026
Q1 		$311K Hold
1,465
– – 0.19% 55
2025
Q4 		$335K Hold
1,465
– – 0.2% 58
2025
Q3 		$339K Hold
1,465
– – 0.2% 59
2025
Q2 		$272K Buy
+1,465
New +$272K 0.18% 60
2025
Q1 		– Sell
-1,465
Closed -$260K – 63
2024
Q4 		$260K Buy
+1,465
New +$269K 0.18% 63

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ames National Corp's ABBV Position: Q2 2026 in Review

Ames National Corp held its AbbVie (ABBV) position steady in Q2 2026 at 1,465 shares worth $369K. The position accounts for 0.2% of the portfolio, ranked #53.

Ames National Corp first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ames National Corp held 1,465 shares of AbbVie worth $369K as of Q2 2026.
  • Ames National Corp left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.2% of Ames National Corp's portfolio in Q2 2026, its #53 holding.
  • Ames National Corp first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ames National Corp's 13F filing for Q2 2026, filed 13 Aug 2026.